- Home
- BIOR
as 07-26-2024 4:00pm EST
Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 21.7M | IPO Year: | 2020 |
| Target Price: | $15.00 | AVG Volume (30 days): | 235.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.83 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.47 - $3.95 | Next Earning Date: | 08-12-2024 |
| Revenue: | $544,000 | Revenue Growth: | 172.00% |
| Revenue Growth (this year): | 13185.5% | Revenue Growth (next year): | 859.69% |
Latest Biora Therapeutics Inc. News
BIOR Breaking Stock News: Dive into BIOR Ticker-Specific Updates for Smart Investing
GlobeNewswire
8 days ago
Biora Therapeutics Announces Supplemental Data from Phase 1 Clinical Trial of BT-600 as Presented at KOL Event
GlobeNewswire
18 days ago
Biora Therapeutics to Host Virtual KOL Event on NaviCap™ Targeted Oral Delivery Platform and Results from Phase 1 Clinical Trial of BT-600 on July 17, 2024
Zacks Small Cap Research
19 days ago
BIOR: BT-600 Topline
GlobeNewswire
25 days ago
Biora Therapeutics Announces Positive Clinical Trial Results for BT-600
GlobeNewswire
a month ago
Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next Gen Peptide Formulation & Delivery Summit 2024
GlobeNewswire
2 months ago
Biora Therapeutics Presents Clinical Data on Device Function of the NaviCap™ Platform at Digestive Disease Week 2024
Zacks Small Cap Research
2 months ago
BIOR: BT-600 Data in June
GuruFocus.com
2 months ago
Biora Therapeutics Inc (BIOR) Q1 2024 Earnings Call Transcript Highlights: Navigating Through ...
Compare BIOR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BIOR Biora Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.